SG10201605080VA - Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol - Google Patents
Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycolInfo
- Publication number
- SG10201605080VA SG10201605080VA SG10201605080VA SG10201605080VA SG10201605080VA SG 10201605080V A SG10201605080V A SG 10201605080VA SG 10201605080V A SG10201605080V A SG 10201605080VA SG 10201605080V A SG10201605080V A SG 10201605080VA SG 10201605080V A SG10201605080V A SG 10201605080VA
- Authority
- SG
- Singapore
- Prior art keywords
- salt
- propylene glycol
- solution containing
- hyaluronic acid
- ophthalmic solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011139566 | 2011-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201605080VA true SG10201605080VA (en) | 2016-08-30 |
Family
ID=47422693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201605080VA SG10201605080VA (en) | 2011-06-23 | 2012-06-22 | Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140088039A1 (en) |
| EP (1) | EP2684560A4 (en) |
| JP (1) | JP5981783B2 (en) |
| KR (1) | KR101906631B1 (en) |
| CN (1) | CN103608000B (en) |
| AU (2) | AU2012274367A1 (en) |
| BR (1) | BR112013033060A2 (en) |
| CA (1) | CA2839822A1 (en) |
| EA (1) | EA025078B1 (en) |
| GE (1) | GEP20166459B (en) |
| HK (1) | HK1190089A1 (en) |
| MX (1) | MX345216B (en) |
| MY (1) | MY176112A (en) |
| SG (1) | SG10201605080VA (en) |
| TW (2) | TWI704931B (en) |
| WO (1) | WO2012176865A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201901426WA (en) * | 2015-03-06 | 2019-03-28 | Santen Pharmaceutical Co Ltd | Ophthalmic composition |
| JP7154764B2 (en) * | 2015-12-22 | 2022-10-18 | 日油株式会社 | Tear lipid layer stabilizer and ophthalmic solution containing the same |
| FR3063649B1 (en) * | 2017-03-07 | 2021-05-21 | Laboratoire De Rhumatologie Appliquee | NEW VISCO-ELASTIC SOLUTION AND ITS USE IN RHEUMATOLOGY |
| KR102268002B1 (en) | 2018-12-26 | 2021-06-23 | (주)휴온스 | Sustained Release Eye-drop Composition |
| KR20230126522A (en) * | 2022-02-23 | 2023-08-30 | 주식회사 스카이테라퓨틱스 | A structure of polymer hyaluronic acid, manufacturing method thereof and eye drop composition comprising the same |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5322667A (en) * | 1987-03-31 | 1994-06-21 | Sherman Pharmaceuticals, Inc. | Preservative system for ophthalmic and contact lens solutions and method for cleaning disinfecting and storing contact lenses |
| JPH01115902A (en) | 1987-10-30 | 1989-05-09 | Showa Sangyo Co Ltd | Production of hyaluronic acid |
| JP2530491B2 (en) * | 1988-12-20 | 1996-09-04 | 参天製薬株式会社 | Hyaluronic acid eye drops |
| JPH1072376A (en) * | 1996-09-02 | 1998-03-17 | Ofutekusu:Kk | Eye drop aqueous solution comprising hyaluronic acid |
| CA2396524C (en) * | 1999-12-27 | 2010-08-03 | Santen Pharmaceutical Co., Ltd. | System for stabilizing lacrimal fluid layer |
| US20060142169A1 (en) * | 2000-11-08 | 2006-06-29 | Bioconcept Laboratories | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| JP2002193815A (en) * | 2000-12-25 | 2002-07-10 | Ophtecs Corp | Eye drops for prevention of corneal drying for ophthalmic operation |
| JP2003002837A (en) * | 2001-06-21 | 2003-01-08 | Lion Corp | Composition for aqueous skin care preparation and method for preventing clouding of liquid composition |
| JP4694773B2 (en) * | 2003-06-06 | 2011-06-08 | ロート製薬株式会社 | Mucosal liquid composition |
| PT2522365T (en) * | 2004-11-24 | 2017-02-08 | Meda Pharmaceuticals Inc | Compositions comprising azelastine and methods of use thereof |
| CN1939534B (en) * | 2005-09-27 | 2010-12-01 | 长春金赛药业股份有限公司 | Externally-applied preparation containing human growth incretion or human granular leukocyte macrophage stimulus factor for treating injury ulceration |
| WO2007074904A1 (en) * | 2005-12-28 | 2007-07-05 | Wakamoto Pharmaceutical Co., Ltd. | Aqueous pharmaceutical composition |
| WO2008011836A2 (en) * | 2006-07-25 | 2008-01-31 | Osmotica Corp. | Ophthalmic solutions |
| JPWO2008044734A1 (en) * | 2006-10-12 | 2010-02-18 | 杏林製薬株式会社 | Gatifloxacin-containing aqueous solution |
| JP2009161454A (en) | 2007-12-28 | 2009-07-23 | Lion Corp | Ophthalmic composition |
| JP2009196903A (en) | 2008-02-19 | 2009-09-03 | Lion Corp | Composition for ophthalmic use |
| EP2308468A1 (en) * | 2009-10-08 | 2011-04-13 | Novaliq GmbH | Novel pharmaceutical composition comprising a macrolide immunosuppressant drug |
| JP5518608B2 (en) * | 2010-07-09 | 2014-06-11 | ロート製薬株式会社 | Mucosal liquid composition |
-
2012
- 2012-06-22 US US14/116,459 patent/US20140088039A1/en not_active Abandoned
- 2012-06-22 TW TW106116311A patent/TWI704931B/en active
- 2012-06-22 CA CA2839822A patent/CA2839822A1/en not_active Abandoned
- 2012-06-22 KR KR1020137034299A patent/KR101906631B1/en active IP Right Grant
- 2012-06-22 CN CN201280029945.5A patent/CN103608000B/en active Active
- 2012-06-22 MX MX2013015273A patent/MX345216B/en active IP Right Grant
- 2012-06-22 TW TW101122328A patent/TW201309306A/en unknown
- 2012-06-22 GE GEAP201213357A patent/GEP20166459B/en unknown
- 2012-06-22 AU AU2012274367A patent/AU2012274367A1/en not_active Abandoned
- 2012-06-22 EP EP12802671.3A patent/EP2684560A4/en not_active Withdrawn
- 2012-06-22 SG SG10201605080VA patent/SG10201605080VA/en unknown
- 2012-06-22 BR BR112013033060A patent/BR112013033060A2/en not_active IP Right Cessation
- 2012-06-22 MY MYPI2013004514A patent/MY176112A/en unknown
- 2012-06-22 EA EA201490127A patent/EA025078B1/en not_active IP Right Cessation
- 2012-06-22 WO PCT/JP2012/065957 patent/WO2012176865A1/en active Application Filing
- 2012-06-22 JP JP2012140951A patent/JP5981783B2/en active Active
-
2014
- 2014-04-04 HK HK14103291.4A patent/HK1190089A1/en not_active IP Right Cessation
-
2017
- 2017-06-09 AU AU2017203905A patent/AU2017203905B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013028599A (en) | 2013-02-07 |
| CN103608000B (en) | 2016-05-11 |
| EA025078B1 (en) | 2016-11-30 |
| US20140088039A1 (en) | 2014-03-27 |
| EA201490127A1 (en) | 2014-04-30 |
| TW201742620A (en) | 2017-12-16 |
| AU2012274367A1 (en) | 2014-01-23 |
| AU2017203905B2 (en) | 2019-07-11 |
| JP5981783B2 (en) | 2016-08-31 |
| EP2684560A1 (en) | 2014-01-15 |
| TW201309306A (en) | 2013-03-01 |
| BR112013033060A2 (en) | 2017-01-24 |
| NZ618822A (en) | 2015-07-31 |
| MX2013015273A (en) | 2014-04-14 |
| MX345216B (en) | 2017-01-18 |
| MY176112A (en) | 2020-07-24 |
| AU2017203905A1 (en) | 2017-06-29 |
| EP2684560A4 (en) | 2014-08-06 |
| KR20140041586A (en) | 2014-04-04 |
| HK1190089A1 (en) | 2014-06-27 |
| TWI704931B (en) | 2020-09-21 |
| CN103608000A (en) | 2014-02-26 |
| KR101906631B1 (en) | 2018-10-10 |
| GEP20166459B (en) | 2016-04-11 |
| WO2012176865A1 (en) | 2012-12-27 |
| CA2839822A1 (en) | 2012-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1201770A1 (en) | Antiseptic cap equipped syringe | |
| DK3061401T3 (en) | Tissue container | |
| EP3190186C0 (en) | Expression of mirnas in placental tissue | |
| PL2742051T3 (en) | Amorpous form of the dolutegravir sodium salt | |
| PL2400993T3 (en) | Sterile hyaluronic acid solutions | |
| IL235425B (en) | Lysin-glutamic acid dipeptide derivatives | |
| EP2799494A4 (en) | Polyamic acid solution | |
| EP2667846A4 (en) | Personal cleansing systems exhibiting low eye irritation potential | |
| EP2730582A4 (en) | Ionic liquid | |
| HK1210271A1 (en) | Ophthalmic devices for delivery of beneficial agents | |
| HK1210941A1 (en) | Modified hyaluronic acid derivatives and use thereof | |
| HK1190089A1 (en) | Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol | |
| HK1207964A1 (en) | Aqueous ophthalmic composition | |
| EP2768739A4 (en) | Eyewash container | |
| HK1196535A1 (en) | Salt and medical use | |
| HK1203480A1 (en) | Ophthalmic formulation | |
| EP2661272A4 (en) | Artificial saliva comprising hyaluronic acid | |
| EP2696876A4 (en) | Aqueous ophthalmic composition | |
| EP2700429A4 (en) | Drug solution applicator | |
| HK1192140A1 (en) | Aqueous ophthalmic composition | |
| GB2519923B (en) | Ophthalmic surgery | |
| ES1076415Y (en) | BATTERY CONTAINER BANNED BURIAL | |
| EP2671561A4 (en) | Medicine storage container | |
| GB201217405D0 (en) | Protein removal agent | |
| GB201215621D0 (en) | Medical solution |